178 related articles for article (PubMed ID: 1776031)
1. Case report 701: Prostaglandin E1 (PGE1) periostitis.
Rowley RF; Lawson JP
Skeletal Radiol; 1991; 20(8):617-9. PubMed ID: 1776031
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin-induced hyperostosis. A case report.
Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
[TBL] [Abstract][Full Text] [Related]
3. Gastric thumbprinting: diffuse gastric wall mucosal and submucosal thickening in infants with ductal-dependent cyanotic congenital heart disease maintained on long-term prostaglandin therapy.
Joshi A; Berdon WE; Brudnicki A; LeQuesne G; Ruzal-Shapiro C; Hayes C
Pediatr Radiol; 2002 Jun; 32(6):405-8. PubMed ID: 12029339
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E1-Induced Periostitis and Reversibility with Discontinuation.
Badheka A; Bangalore Prakash P; Allareddy V
J Pediatr; 2017 Oct; 189():237-237.e1. PubMed ID: 28709628
[No Abstract] [Full Text] [Related]
5. Gastric outlet obstruction due to an iatrogenic cause in a neonatal period - report of two cases.
Kosiak W; Swieton D; Fryze I; Aleszewicz-Baranowska J; Duklas M; Chojnicki M
Ultraschall Med; 2009 Aug; 30(4):401-3. PubMed ID: 17610180
[TBL] [Abstract][Full Text] [Related]
6. Nursing care of the neonate receiving prostaglandin E1 therapy.
Rikard DH
Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
[TBL] [Abstract][Full Text] [Related]
7. Pseudo-Bartter syndrome in a neonate on prostaglandin infusion.
Vanhaesebrouck S; Allegaert K; Vanhole C; Devlieger H; Gewillig M; Proesmans W
Eur J Pediatr; 2003 Sep; 162(9):569-71. PubMed ID: 12811550
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.
Akkinapally S; Hundalani SG; Kulkarni M; Fernandes CJ; Cabrera AG; Shivanna B; Pammi M
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011417. PubMed ID: 29486048
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin-induced neonatal periostitis.
Letts M; Pang E; Simons J
J Pediatr Orthop; 1994; 14(6):809-13. PubMed ID: 7814600
[TBL] [Abstract][Full Text] [Related]
10. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
Kalloghlian AK; Frayha HH; deMoor MM
Eur J Pediatr; 1996 Mar; 155(3):173-4. PubMed ID: 8929722
[TBL] [Abstract][Full Text] [Related]
11. Periosteal changes secondary to prostaglandin administration.
Ringel RE; Haney PJ; Brenner JI; Mancuso TJ; Roberts GS; Moulton AL; Berman MA
J Pediatr; 1983 Aug; 103(2):251-3. PubMed ID: 6683753
[No Abstract] [Full Text] [Related]
12. Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation.
Saji T; Matsuura H; Hoshino K; Yamamoto S; Ishikita T; Matsuo N
Jpn Heart J; 1991 Sep; 32(5):735-40. PubMed ID: 1774835
[TBL] [Abstract][Full Text] [Related]
13. Prolonged prostaglandin E1 infusion in an infant with cyanotic congenital heart disease.
Lewis AB; Lurie PR
Pediatrics; 1978 Apr; 61(4):534-6. PubMed ID: 662477
[TBL] [Abstract][Full Text] [Related]
14. Plain film and CT observations in prostaglandin-induced bone changes.
Matzinger MA; Briggs VA; Dunlap HJ; Udjus K; Martin DJ; McDonald P
Pediatr Radiol; 1992; 22(4):264-6. PubMed ID: 1523047
[TBL] [Abstract][Full Text] [Related]
15. Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.
Leonhardt A; Schweer H; Wolf D; Seyberth HW
Br J Clin Pharmacol; 1992 Mar; 33(3):323-5. PubMed ID: 1576056
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
[TBL] [Abstract][Full Text] [Related]
17. Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.
Lacher M; Schneider K; Dalla Pozza R; Schweinitz DV
Eur J Pediatr Surg; 2007 Oct; 17(5):362-4. PubMed ID: 17968795
[TBL] [Abstract][Full Text] [Related]
18. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation.
Huang FK; Lin CC; Huang TC; Weng KP; Liu PY; Chen YY; Wang HP; Ger LP; Hsieh KS
Pediatr Neonatol; 2013 Apr; 54(2):102-6. PubMed ID: 23590954
[TBL] [Abstract][Full Text] [Related]
19. Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant.
Strauss A; Modanlou HD; Gyepes M; Wittner R
Am J Dis Child; 1982 Oct; 136(10):934-6. PubMed ID: 6889810
[TBL] [Abstract][Full Text] [Related]
20. Altered prostaglandin E1 dosage during extracorporeal membrane oxygenation in a newborn with ductal-dependent congenital heart disease.
Stone DM; Frattarelli DA; Karthikeyan S; Johnson YR; Chintala K
Pediatr Cardiol; 2006; 27(3):360-3. PubMed ID: 16565906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
